Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial

Abstract Background Medications currently recommended for the treatment of Obsessive-Compulsive Disorder (OCD) usually relieve the severity of symptoms by as much as 20-30%, and satisfactory treatment is obtained in 40-60% of patients with OCD. Nevertheless, the remaining symptoms continue to impair...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ala Ghobadian (Autor), Saba Mokhtari (Autor), Behnam Shariati (Autor), Leila Kamalzadeh (Autor), Mohsen Shati (Autor), Mehrdad Eftekhar Ardebili (Autor), Masoomeh Yarahmadi (Autor), Mohammadreza Shalbafan (Autor)
Médium: Kniha
Vydáno: BMC, 2022-09-01T00:00:00Z.
Témata:
On-line přístup:Connect to this object online.
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

Connect to this object online.

3rd Floor Main Library

Informace o exemplářích z: 3rd Floor Main Library
Signatura: A1234.567
Jednotka 1 Dostupné